Impact of cardiometabolic index on cardiovascular-kidney-metabolic syndrome stage progression: a nationwide prospective cohort study

Back

ESC2025 Premium Access

Impact of cardiometabolic index on cardiovascular-kidney-metabolic syndrome stage progression: a nationwide prospective cohort study

Session: Cardiometabolic diseases (1)

Topic: Biomarkers

Speaker: Miss S. Wu (Beijing, CN)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Miss Shuang Wu

Fuwai Hospital, CAMS and PUMC, Beijing (China)

0 follower

7 more presentations in this session

Comparison of nutritional risk scores for predicting cardiovascular morbidity and mortality in incident haemodialysis patients

Speaker: Assistant Professor H. Takahashi (Toyoake, JP)

Cardiovascular disease burden attributable to decreased estimated glomerular filtration rate: insights from the ATTICA study (2002-2022)

Speaker: Miss E. Damigou (Athens, GR)

Impact of body mass index and prediabetes on the risk of type 2 diabetes and cardiovascular events following a recent myocardial infarction

Speaker: Doctor P. Tonnesen (Aarhus, DK)

Associations of metabolic vulnerability index with cardiometabolic diseases, multimorbidity, and all-cause mortality

Speaker: Doctor S. Zhu (Hangzhou, CN)

Blood pressure, glycemic, and cholesterol control among adults with atherosclerotic cardiovascular disease in the United States, 2013 to 2023

Speaker: Doctor J. Gong (Boston, US)

Access the full session

Cardiometabolic diseases (1)

Speakers: Miss S. Wu, Assistant Professor H. Takahashi, Miss E. Damigou, Doctor P. Tonnesen, Doctor S. Zhu...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources